Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Condition(s):Acute Myeloid LeukemiaLast Updated:December 25, 2009Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:December 25, 2009Unknown status
Condition(s):Relapsed/Refractory Acute Myeloid LeukemiaLast Updated:September 21, 2022Not yet recruiting
Condition(s):Relapsed/Refractory Acute Myeloid LeukemiaLast Updated:January 12, 2023Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:December 7, 2016Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:May 24, 2023Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:April 20, 2020Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:March 31, 2020Withdrawn
Condition(s):Acute Lymphoblastic Leukemia; Acute Myeloid LeukemiaLast Updated:November 15, 2023Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:June 8, 2021Unknown status
Condition(s):Acute Myelogenous Leukemia; Myelodysplastic SyndromeLast Updated:August 8, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.